DOT1L and neoplasm: PsA-3091, a heteromonomeric structured analog with a tertiary butyl functional group at the aromatic ring, showed the most effective and selective inhibition towards DOT1L activity, along with suppression of tumor growth and metastasis in TNBC cells [18].